Skip to main navigation Skip to search Skip to main content

A case of gabapentin-induced rhabdomyolysis requiring renal replacement therapy

  • Min Seok Choi
  • , Howook Jeon
  • , Hyo Suk Kim
  • , Bo Hyun Jang
  • , Yoon Hee Lee
  • , Hoon Suk Park
  • , Hyung Wook Kim
  • , Dong Chan Jin
  • The Catholic University of Korea, St. Vincent's Hospital

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Gabapentin is commonly used for controlling convulsions, restless pain syndrome, and pain in diabetic neuropathy. Common side effects include dizziness, somnolence, ataxia, peripheral edema, and confusion; gabapentin-induced rhabdomyolysis is rarely reported. To date, the reported cases of gabapentin-induced rhabdomyolysis have been associated with patients with multiple underlying diseases and assuming multiple medicines for various reasons. In this report, we describe a case of gabapentin-induced rhabdomyolysis in a 32-year-old woman with no medical history. We also review related literature and discuss the possible mechanism and the association with other factors. This case shows that gabapentin can induce rhabdomyolysis in healthy patients and that clinicians must consider the possible association between gabapentin and rhabdomyolysis.

Original languageEnglish
Pages (from-to)E4-E8
JournalHemodialysis International
Volume21
Issue number1
DOIs
StatePublished - 1 Jan 2017

Bibliographical note

Publisher Copyright:
© 2016 International Society for Hemodialysis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Gabapentin
  • renal replacement therapy
  • rhabdomyolysis

Fingerprint

Dive into the research topics of 'A case of gabapentin-induced rhabdomyolysis requiring renal replacement therapy'. Together they form a unique fingerprint.

Cite this